Cargando…
Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity
Autores principales: | Watson, Adrienne L., Keller, Bryant J., Williams, Kyle A., Damle, Namrata N., Finnerty, Samuel J., Anderson, Leah K., Greeley, Andrew D., Keng, Vincent W., Rahrmann, Eric P., Halfond, Amanda L., Powell, Natasha M., Collins, Margaret H., Rizvi, Tilat, Moertel, Christopher L., Ratner, Nancy, Largaespada, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533073/ https://www.ncbi.nlm.nih.gov/pubmed/33062197 http://dx.doi.org/10.18632/oncotarget.27349 |
Ejemplares similares
-
Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity
por: Watson, Adrienne L., et al.
Publicado: (2014) -
Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST
por: Keng, Vincent W., et al.
Publicado: (2012) -
Cd44 Enhances Neuregulin Signaling by Schwann Cells
por: Sherman, Larry S., et al.
Publicado: (2000) -
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and genetic pathways driving tumorigenesis
por: Rahrmann, Eric P, et al.
Publicado: (2013) -
P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis
por: Patritti Cram, Jennifer, et al.
Publicado: (2022)